Status:
COMPLETED
Reduction of Postoperative Gastrointestinal Dysmotility Following Total Laparoscopic Hysterectomy.
Lead Sponsor:
The Cleveland Clinic
Collaborating Sponsors:
Michael Sprague MD
Pamela Frazzini-Padilla MD
Conditions:
Postoperative Passage of Flatus
Postoperative Bowel Movement
Eligibility:
FEMALE
18-85 years
Phase:
PHASE4
Brief Summary
Return of bowel function is an integral component of postoperative recovery following minimally invasive gynecologic surgery. To date, there is no standardized regimen to optimize bowel motility posto...
Detailed Description
Patients undergoing minimally invasive hysterectomy at Cleveland Clinic Florida Department of Minimally Invasive Gynecologic Surgery will be recruited at their preoperative visit or over the phone. In...
Eligibility Criteria
Inclusion
- aged 18-85 undergoing minimally invasive gynecologic surgery in the form of total laparoscopic hysterectomy.
Exclusion
- an underlying gynecologic malignancy, pre-existing gastrointestinal disorders, history of bowel resection, insulin-dependent diabetes or gastroparesis, known gastric dysmotility, chronic use of pain medications, or anticipated bowel surgery
Key Trial Info
Start Date :
November 9 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 5 2020
Estimated Enrollment :
81 Patients enrolled
Trial Details
Trial ID
NCT03800745
Start Date
November 9 2018
End Date
May 5 2020
Last Update
June 2 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Cleveland Clinic Florida
Weston, Florida, United States, 33331